jump to content jump to footer

Objective, reproducible, and trustworthy data in clinical trials with imaging endpoints

Dr. Anthony Tolcher, medical oncologist and CEO of NEXT Oncology, spoke to us about objectivity as one of the biggest challenges in clinical trials and how a software solution for tumor assessment can improve the quality and reproducibility of data, all while saving time.

Moreover, such software solutions are a key aspect for the approval of novel drugs based on small sample size – like for example targeted or tissue agnostic medicine, as a significant advance for precision therapies. Dr. Tolcher describes how mint Lesion™ assists in generating trustworthy data, “so that [one] can ensure that the drugs that are getting approved really do work.”

Video Clinical Trials Standardized Reading Procedures Therapy Response Assessment Structured Reporting

Related Resources

Radiologist analyzing whole-body MRI scans of prostate cancer bone metastases using AI-assisted tumor load quantification in mint Lesion
How mint Lesion supports radiologists in AI-assisted tumor load quantification for bone metastases in prostate cancer with structured analysis, objective metrics, and longitudinal therapy assessment.
AI-Supported Tumor Load Quantification for Bone Metastasis in Prostate Cancer
To assess treatment response in patients with advanced prostate cancer, radiologists rely on advanced medical imaging. Conventional modalities, such…
Radiologists participating in a hands-on lung cancer screening workshop using structured reporting software mint Lesion at RÖKO 2026
Interactive hands-on workshop on lung cancer screening according to G-BA guidelines at RÖKO 2026, including structured reporting, double reading workflows, and consensus decision-making
Hands-On Workshop Lung Cancer Screening: From Initial Read to Consenus
From initial read to consensus – structured reporting in practice at RÖKO 2026
Radiologist using mint Lesion for structured lung cancer screening reporting and AI-assisted lung nodule assessment
How mint Lesion supports radiologists in the German lung cancer screening program through structured reporting, AI-supported workflows, second reading, and longitudinal patient follow-up.
Lung Cancer Screening in Germany: How mint Lesion Supports Radiologists in Clinical Practice
A New Era of Early Detection — and New Challenges With the introduction of the nationwide lung cancer screening program starting in 2026,…